Janux Therapeutics, Inc. - JANX

Sector: Healthcare · Industry: Pharmaceutical Preparations
Website: No information yet · Social: No information yet

Company profile

Powered by TradingView

Quarter snapshot

Latest / Compare
Q2 2026 · Q1 2026
Value (USD)
Total reported value ($000)
$998.7M
QoQ value delta ($000)
+$158.9M (+18.92%)
Implied price effect (QoQ)
+9.84%
Shares
Total shares
65,446,462
QoQ shares delta
+4,997,430 (+8.27%)
Total shares held by funds (by quarter)

Market chart (JANX)

Powered by TradingView
Interactive chart by TradingView.

Top holders (Q2 2026)

Top 25 only Full list
Partial Q2 2026 data: 199 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
Manager Value ($000) Shares % of 13F
RA CAPITAL MANAGEMENT, L.P. 171,873 11,189,693 1.49%
BlackRock, Inc. 94,228 6,134,667 0.0%
Prosight Management, LP 58,436 3,804,481 10.07%
JANUS HENDERSON GROUP PLC 58,279 4,196,409 0.03%
STATE STREET CORP 46,155 3,004,899 0.0%
FMR LLC 37,060 2,412,825 0.0%
FEDERATED HERMES, INC. 36,140 2,352,927 0.05%
Point72 Asset Management, L.P. 30,625 1,993,837 0.03%
VANGUARD CAPITAL MANAGEMENT LLC 28,528 1,857,351 0.0%
TCG Crossover Management, LLC 27,488 1,789,617 0.66%
Alyeska Investment Group, L.P. 25,300 1,647,140 0.07%
WELLINGTON MANAGEMENT GROUP LLP 23,153 1,507,360 0.0%
VANGUARD PORTFOLIO MANAGEMENT LLC 20,439 1,330,710 0.0%
CITADEL ADVISORS LLC 19,427 1,264,837 0.0%
TWO SIGMA INVESTMENTS, LP 18,543 1,207,250 0.01%
GEODE CAPITAL MANAGEMENT, LLC 18,499 1,204,150 0.0%
ALGERT GLOBAL LLC 17,063 1,110,889 0.2%
D. E. Shaw & Co., Inc. 16,842 1,096,509 0.01%
GOLDMAN SACHS GROUP INC 14,633 952,675 0.0%
BANK OF AMERICA CORP /DE/ 13,984 910,460 0.0%
MORGAN STANLEY 12,855 836,966 0.0%
Nantahala Capital Management, LLC 12,440 809,914 0.41%
Qube Research & Technologies Ltd 10,783 702,057 0.01%
Squarepoint Ops LLC 8,176 532,321 0.01%
ORBIMED ADVISORS LLC 8,059 524,700 0.15%